A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

The 5 μg and 10 μg adjuvanted EV71 vaccines are generally safe and immunogenic in healthy adults. (ClinicalTrials.gov number, NCT01268787).